Medulloblastoma
What's New
Last Posted: Nov 02, 2023
- Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States.
Baylee Roy et al. Pediatr Blood Cancer 2023 e30725 - Deep learning based clinico-radiological model for paediatric brain tumor detection and subtype prediction.
Abhishek Mahajan et al. Explor Target Antitumor Ther 2023 4(4) 669-684 - Multiparametric MRI-Based Radiomics Signature with Machine Learning for Preoperative Prediction of Prognosis Stratification in Pediatric Medulloblastoma.
Yi Luo et al. Acad Radiol 2023 - Radiomics-based machine learning models for prediction of medulloblastoma subgroups: a systematic review and meta-analysis of the diagnostic test performance.
Karabacak Mert et al. Acta radiologica (Stockholm, Sweden : 1987) 2022 2841851221143496 - Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.
Miller Alexandra M et al. Neuro-oncology 2022 - Artificial Intelligence Applications in Pediatric Brain Tumor Imaging: A Systematic Review.
Huang Jonathan et al. World neurosurgery 2021 - Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology members.
Fortin Ensign Shannon et al. Neuro-oncology practice 2021 8(3) 310-316 - Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution.
Wang Ying et al. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020 Sep - Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging.
Zhou H et al. AJNR. American journal of neuroradiology 2020 Jul 41(7) 1279-1285 - Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
Yeo Kee Kiat et al. Journal of neuro-oncology 2019 Oct
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: